Page last updated: 2024-08-23

plicamycin and vorinostat

plicamycin has been researched along with vorinostat in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Becker, JC; Fan, K; Nghiem, P; Paulson, KG; Ritter, C; Schrama, D	1

Other Studies

1 other study(ies) available for plicamycin and vorinostat

Article	Year
Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma. Scientific reports, 2016, Feb-23, Volume: 6 Topics: Acetylation; Animals; Carcinoma, Merkel Cell; Cell Line, Tumor; Cytotoxicity, Immunologic; Gene Silencing; Histocompatibility Antigens Class I; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Killer Cells, Lymphokine-Activated; Mice; Mice, Inbred NOD; NK Cell Lectin-Like Receptor Subfamily K; Plicamycin; Promoter Regions, Genetic; Signal Transduction; Skin Neoplasms; Vorinostat; Xenograft Model Antitumor Assays	2016

Article

Year

Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma.

Scientific reports, 2016, Feb-23, Volume: 6

Topics: Acetylation; Animals; Carcinoma, Merkel Cell; Cell Line, Tumor; Cytotoxicity, Immunologic; Gene Silencing; Histocompatibility Antigens Class I; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Killer Cells, Lymphokine-Activated; Mice; Mice, Inbred NOD; NK Cell Lectin-Like Receptor Subfamily K; Plicamycin; Promoter Regions, Genetic; Signal Transduction; Skin Neoplasms; Vorinostat; Xenograft Model Antitumor Assays

2016